AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Daratumumab in South Africa
1 product registered with SAHPRA — 1 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| DARZALEX 1 800 mg SOLUTION FOR INJECTION | 57/26/0332 | Janssen Pharmaceutica (Pty) Ltd | active | 12 Mar 2029 |
Daratumumab — SAHPRA Registration Details
SAHPRA (South Africa) has 1 registered product containing Daratumumab, of which 1 is currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Daratumumab registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.